Haemonetics (HAE) Tops Q3 EPS by 3c; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.92 +0.07%
EPS Growth %: 0.0%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.85, $0.03 better than the analyst estimate of $0.82. Revenue for the quarter came in at $305.3 million versus the consensus estimate of $299.08 million.
GUIDANCE:
Haemonetics sees FY2023 EPS of $2.90-$3.00, versus the consensus of $2.92.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
- Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
